Last updated on February 2019

Long Term Efficacy and Safety of Inhaled Colistimethate Sodium in Bronchiectasis Subjects With Chronic Pseudomonas Aeruginosa Infection.

Brief description of study

The co-primary objectives of the trial are to investigate the effect of the use of inhaled colistimethate sodium, administered twice daily via the I-neb for 24 months, compared to placebo in subjects with non-cystic fibrosis bronchiectasis (NCFB) chronically infected with P. aeruginosa on:

the frequency of pulmonary exacerbations; the number of exacerbation-free days.

Clinical Study Identifier: NCT03093974

Find a site near you

Start Over

Zambon Investigative Site

Valencia, Spain
  Connect »